Plain-English translation of NCT05024162 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Doctors currently use prostate biopsies (small tissue samples) as the gold standard to understand how aggressive a prostate cancer is. This study is testing whether a computer algorithm that analyzes MRI scan images — looking at specific patterns and textures — can predict cancer aggressiveness just as well. If successful, this could help doctors better understand your cancer without always needing a biopsy.
Right now, doctors rely heavily on biopsies to understand how serious a prostate cancer is, but researchers worry that computer predictions from MRI scans might not be reliable or consistent. This trial aims to prove whether the algorithm can give accurate, stable results every time — which could eventually offer patients a less invasive way to assess their cancer.
You will attend two MRI scans of your prostate. Your first scan will be part of your standard care for your prostate cancer diagnosis. A few weeks later, you will come back for a second, additional MRI scan for this study. Both scans will be analyzed using a computer algorithm to see if it consistently predicts your cancer's characteristics, and the results will be compared to your biopsy findings.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Canada